| abstract |
The present invention relates to a compound represented by formula (I), a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the compound or the salt.n(In the formula, R 1 represents a hydrogen atom or the like; -X- represents -S- or the like; =Y- represents =C(R 3 )- or the like; R 3 represents a hydrogen atom or the like; A represents a substituted or unsubstituted aromatic carbocyclic group, a substituted or unsubstituted aromatic heterocyclic group or the like; ring B represents a substituted or unsubstituted aromatic heterocyclic ring, a substituted or unsubstituted non-aromatic carbocyclic ring or the like; ring D represents a substituted or unsubstituted piperazine, a substituted or unsubstituted piperidine, a substituted or unsubstituted morpholine or the like; and ring E represents a substituted or unsubstituted aromatic heterocyclic ring, a substituted or unsubstituted aromatic carbocyclic ring or the like.) |